ConductScience.org, home
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
API referenceFor AI assistants

Trial · NCT04973228

Results by group16

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 16 of 16

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Achievement of Success on the Investigator Global Assessment (IGA) at Week 8Roflumilast Foam 0.3%8095% Confidence Interval 74 to 84percentage of participants
Achievement of Success on the Investigator Global Assessment (IGA) at Week 8Vehicle Foam5895% Confidence Interval 50 to 66percentage of participants
Achievement of Success in the Worst Itch Numeric Rating Scale (WI-NRS) at Week 8Roflumilast Foam 0.3%6395% Confidence Interval 56 to 70percentage of participants
Achievement of Success in the Worst Itch Numeric Rating Scale (WI-NRS) at Week 8Vehicle Foam4195% Confidence Interval 31 to 51percentage of participants
Achievement of Success in the WI-NRS at Week 4Roflumilast Foam 0.3%4895% Confidence Interval 41 to 54percentage of participants
Achievement of Success in the WI-NRS at Week 4Vehicle Foam2995% Confidence Interval 21 to 39percentage of participants
Achievement of Success in the WI-NRS at Week 2Roflumilast Foam 0.3%3395% Confidence Interval 27 to 40percentage of participants
Achievement of Success in the WI-NRS at Week 2Vehicle Foam1695% Confidence Interval 10 to 24percentage of participants
Achievement of Success on the IGA at Week 2Roflumilast Foam 0.3%4395% Confidence Interval 37 to 49percentage of participants
Achievement of Success on the IGA at Week 2Vehicle Foam2695% Confidence Interval 19 to 33percentage of participants
Achievement of Success on the IGA at Week 4Roflumilast Foam 0.3%73.195% Confidence Interval 67.67 to 77.83percentage of participants
Achievement of Success on the IGA at Week 4Vehicle Foam47.195% Confidence Interval 39.19 to 55.10percentage of participants
Achievement of Overall Assessment of Scaling Score of 0 at Week 8Roflumilast Foam 0.3%5895% Confidence Interval 52 to 63percentage of participants
Achievement of Overall Assessment of Scaling Score of 0 at Week 8Vehicle Foam3795% Confidence Interval 29 to 45percentage of participants
Achievement of Overall Assessment of Erythema Score of 0 at Week 8Roflumilast Foam 0.3%5895% Confidence Interval 52 to 63percentage of participants
Achievement of Overall Assessment of Erythema Score of 0 at Week 8Vehicle Foam3295% Confidence Interval 25 to 40percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04973228/results

API referenceFor AI assistants